304 related articles for article (PubMed ID: 18715612)
1. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
[TBL] [Abstract][Full Text] [Related]
2. Proposed histopathologic grading system derived from a study of KIT and CK19 expression in pancreatic endocrine neoplasm.
Zhang L; Lohse CM; Dao LN; Smyrk TC
Hum Pathol; 2011 Mar; 42(3):324-31. PubMed ID: 21190722
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
[TBL] [Abstract][Full Text] [Related]
4. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
[TBL] [Abstract][Full Text] [Related]
5. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic endocrine tumors: radiologic-clinicopathologic correlation.
Lewis RB; Lattin GE; Paal E
Radiographics; 2010 Oct; 30(6):1445-64. PubMed ID: 21071369
[TBL] [Abstract][Full Text] [Related]
7. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
8. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Schmitt AM; Anlauf M; Rousson V; Schmid S; Kofler A; Riniker F; Bauersfeld J; Barghorn A; Probst-Hensch NM; Moch H; Heitz PU; Kloeppel G; Komminoth P; Perren A
Am J Surg Pathol; 2007 Nov; 31(11):1677-82. PubMed ID: 18059224
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens.
Deng H; Shi J; Wilkerson M; Meschter S; Dupree W; Lin F
Am J Clin Pathol; 2008 Jan; 129(1):81-8. PubMed ID: 18089492
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma.
Buishand FO; Kik M; Kirpensteijn J
Vet J; 2010 Jul; 185(1):62-7. PubMed ID: 20570189
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.
Ekeblad S; Skogseid B; Dunder K; Oberg K; Eriksson B
Clin Cancer Res; 2008 Dec; 14(23):7798-803. PubMed ID: 19047107
[TBL] [Abstract][Full Text] [Related]
12. [Endocrine tumors of the pancreas: classification, clinical and molecular prognostic factors].
Terris B
Ann Pathol; 2002 Oct; 22(5):367-74. PubMed ID: 12483154
[TBL] [Abstract][Full Text] [Related]
13. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.
Bettini R; Partelli S; Boninsegna L; Capelli P; Crippa S; Pederzoli P; Scarpa A; Falconi M
Surgery; 2011 Jul; 150(1):75-82. PubMed ID: 21683859
[TBL] [Abstract][Full Text] [Related]
14. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
[TBL] [Abstract][Full Text] [Related]
15. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?
Ferrone CR; Tang LH; Tomlinson J; Gonen M; Hochwald SN; Brennan MF; Klimstra DS; Allen PJ
J Clin Oncol; 2007 Dec; 25(35):5609-15. PubMed ID: 18065733
[TBL] [Abstract][Full Text] [Related]
16. Imaging features of pancreatic neoplasms.
Ros PR; Mortelé KJ
JBR-BTR; 2001; 84(6):239-49. PubMed ID: 11817475
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
19. The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value.
Iino S; Abeyama K; Kawahara K; Yamakuchi M; Hashiguchi T; Matsukita S; Yonezawa S; Taniguchi S; Nakata M; Takao S; Aikou T; Maruyama I
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6179-88. PubMed ID: 15448005
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of atypical histologic features in choroid plexus papilloma.
Jeibmann A; Hasselblatt M; Gerss J; Wrede B; Egensperger R; Beschorner R; Hans VH; Rickert CH; Wolff JE; Paulus W
J Neuropathol Exp Neurol; 2006 Nov; 65(11):1069-73. PubMed ID: 17086103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
